KRAS-G12C in the crosshairs

Nat Rev Cancer. 2020 Jan;20(1):3. doi: 10.1038/s41568-019-0228-3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Humans
  • Mice
  • Neoplasms*
  • Proto-Oncogene Proteins p21(ras)

Substances

  • Antineoplastic Agents
  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)